The possible shortage of EpiPen and EpiPen Jr reported by NBC News and other mainstream media was worrisome but served as a reminder to plan ahead for food allergy-related emergencies, experts told Healio Family Medicine.
“It is always concerning when there is a shortage of a medical treatment, especially when there is one that is needed to treat a life-threatening condition like anaphylaxis,” Michael S. Blaiss, MD, FACAAI, executive medical director, American College of Allergy, Asthma and Immunology, said in an interview.
This activity is supported by an educational grant from DBV Technologies.
View past polls »
Search Healio's robust listing of national and international medical meetings.
Tell us what you think about Healio.com »
Get the latest news and education delivered to your inbox
©2018 Healio All Rights Reserved.